SETD2 Antikörper (AA 2054-2245)
Kurzübersicht für SETD2 Antikörper (AA 2054-2245) (ABIN7193416)
Target
Alle SETD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 2054-2245
-
Verwendungszweck
- SETD2 Antibody
-
Aufreinigung
- Purified antibody
-
Immunogen
- Purified recombinant fragment of human SETD2 (AA: 2054-2245) expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
ELISA: 1/10000
FCM: 1/200 - 1/400
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
- SETD2 (SET Domain Containing 2 (SETD2))
-
Andere Bezeichnung
- SETD2
-
Hintergrund
-
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
-
Molekulargewicht
- 287.6 kDa
-
Pathways
- Tube Formation
Target
-